Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Digestive System Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Digestive System Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 10 | 35177257 | intron variant | T/G | snv | 0.33 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 10 | 35196021 | 5 prime UTR variant | T/G | snv | 0.34 | 0.34 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.160 | 10 | 35208018 | intron variant | G/A | snv | 0.33 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 10 | 35208018 | intron variant | G/A | snv | 0.33 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 10 | 35208018 | intron variant | G/A | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 10 | 35136622 | intron variant | C/T | snv | 0.14 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
10 | 35127641 | intron variant | G/A | snv | 0.14 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
10 | 35127641 | intron variant | G/A | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.040 | 10 | 35199336 | intron variant | C/T | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 10 | 35143477 | intron variant | T/C | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.120 | 10 | 35133175 | intron variant | G/A | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 10 | 35212510 | 3 prime UTR variant | A/G | snv | 0.19 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 10 | 35212510 | 3 prime UTR variant | A/G | snv | 0.19 |
|
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 10 | 35212510 | 3 prime UTR variant | A/G | snv | 0.19 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 10 | 35203904 | intron variant | A/G | snv | 0.32 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 35185771 | intron variant | T/C | snv | 0.33 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 10 | 35207802 | intron variant | A/G | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
10 | 35207699 | intron variant | G/A | snv | 0.14 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.040 | 10 | 35151213 | intron variant | G/A | snv | 0.37 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 |